Optimizing sequential treatment with anti-EGFR and VEGF mAb in metastatic colorectal cancer: current results and controversies

Optimizing sequential treatment with anti-EGFR and VEGF mAb in metastatic colorectal cancer: current results and controversies

Datian Chen,1 Kaikai Gu,2 Huiyu Wang3 1Department of Oncology, Haimen People’s Hospital, Haimen, People’s Republic of China; 2Haimen Hospital of Traditional Chinese Medicine, Haimen, People’s Republic of China; 3Wuxi People’s Hospital Affiliated to Nanjing Med...

Full description

Bibliographic Details
Main Authors: Chen DT, Gu KK, Wang HY
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:Cancer Management and Research
Subjects:
anti-EGFR mAb
bevacizumab
treatment sequence
metastatic colorectal cancer
Online Access:https://www.dovepress.com/optimizing-sequential-treatment-with-anti-egfr-and-vegf-mab-in-metasta-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/optimizing-sequential-treatment-with-anti-egfr-and-vegf-mab-in-metasta-peer-reviewed-article-CMAR

Similar Items